7 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... HAS-BLED schemas #Diagnosis ... #Hematology #CHADS2 ... #Anticoagulation ... #AFib
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
risk and bleed ... risk on anticoagulation ... #Anticoagulation ... #AFib #Diagnosis ... #Hematology
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
Renal Dosing: Apixaban ... AFib: CrCl 15-50 ... OralAnticoagulant #Anticoagulation ... #Hematology #Pharmacology ... #Apixaban #Rivaroxaban
CHADSVASc Score - Stroke Risk in Atrial Fibrillation

A clinical mnemonic to estimate stroke risk in atrial
Risk in Atrial ... risk in atrial ... decisions regarding anticoagulation ... #Fibrillation #AFib ... #CHADS2VASc #Diagnosis
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
cardiovascular risk ... (< 5% pts with afibb ... (rivaroxaban, apixaban ... #Fibrillation #AFib ... #diagnosis #management
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Differential Diagnosis ... • Seizures • Strokes ... Cardiac valve vegetations ... Thrombosis highest risk ... Erythematosus #Diagnosis
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
appropriate only for low risk ... patients with no CV risk ... Hydroxyurea + anticoagulation ... Thrombocythemia #ET #hematology ... #hematology